Behind the Bench

When PCR Gets Dirty – Tackling PCR Inhibitors

In this first Absolute Gene-ius: Science Snapshot episode, h... Jordan Ruggieri, MBA by / 03.24.2026

Overview Predictable scale-up in pharmaceutical extrusion ... Dirk Leister by / 03.17.2026

As fragmentomics gains momentum in cancer liquid biopsy rese... by Behind The Bench Staff / 03.05.2026

On the Absolute Gene-ius podcast, Lexi Heger, PhD candidate ... Jordan Ruggieri, MBA by / 02.28.2026

In this episode of Absolute Gene-ius, we explore how digital... Jordan Ruggieri, MBA by / 02.27.2026

The United States National Institutes of Health has prioriti... by Behind The Bench Staff / 02.25.2026

Drug discovery capabilities continue to advance rapidly. Med... Dirk Leister by / 02.17.2026

In cell therapy manufacturing, the lack of definitive regula... Tanuka Biswas, PhD by / 02.12.2026

As pharmaceutical pipelines evolve, manufacturing strategies... Dirk Leister by / 02.03.2026

For Dr. Harald Bartsch, a clinical pathologist in southern B... by Behind The Bench Staff / 01.13.2026

Name
This field is for validation purposes and should be left unchanged.
First Name
Last Name
Email*
Company
Select your country/region*
Pick a category*
*
- I would like to receive information about content, events, products, services and promotions from Thermo Fisher Scientific and its affiliates. I agree for the Thermo Fisher Scientific group (thermofisher.com/legalentities) to contact me by email and/or telephone to inform me of events, products, services and/or promotions offered in connection with the brands Thermo Scientific™, Applied Biosystems™, Invitrogen™, Gibco™, Ion Torrent ™, Unity Lab Services™, Fisher Scientifc™. I can withdraw my consent and unsubscribe at any time by emailing reply@thermofisher.com By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Thermo Fisher Scientific Policy (thermofisher.com/privacypolicy).